Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  lutetium Lu 177-DOTA-octreotate
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: AAA-III-01, NCI-2012-02037, 2011-005049-11, NCT01578239
Start Over